Skip to main content
Cytogen, Inc. logo

Cytogen, Inc. — Investor Relations & Filings

Ticker · 217330 ISIN · KR7217330000 KO Manufacturing
Open in API
Filings indexed 437 across all filing types
Latest filing 2024-01-03 Major Shareholding Noti…
Country KR South Korea
Listing KO 217330

About Cytogen, Inc.

https://www.cytogenlab.com/

Cytogen, Inc. is a biotechnology company specializing in liquid biopsy platforms for precision oncology. The company has developed proprietary technology for the rapid isolation and analysis of viable Circulating Tumor Cells (CTCs) from whole blood. Its core offering, the SmartBiopsy Platform, utilizes a high-density microporous chip with microfluidics and nanotechnology to capture CTCs efficiently. This non-invasive diagnostic approach is designed to support early cancer detection, treatment monitoring, and the advancement of personalized medicine for cancer patients.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in Korea. This type of filing is required when an entity's shareholding in a company crosses certain thresholds (typically 5%). It details the identity of the shareholder, the number of shares held, and the purpose of the holding (in this case, 'simple investment'). This falls under the category of Major Shareholding Notification.
2024-01-03 Korean
기타시장안내(최대주주의의무보유관련)(최대주주의 의무보유 이행 관련)
Major Shareholding Notification Classification · 100% confidence The document is a short regulatory announcement from the Korea Exchange regarding Cytogen's major shareholder lock-up obligations. It is not a financial report, but rather a market notice/regulatory update concerning compliance with KOSDAQ listing rules. Since it does not fit into specific categories like M&A, dividends, or share repurchases, it falls under the general regulatory filing category.
2024-01-03 Korean
주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (임시주주총회) for the company CytoGen. It details the date, time, location, and agenda items (such as the appointment of directors) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the meeting and request their participation/vote, which falls under the Proxy Solicitation & Information Statement category.
2024-01-02 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice from the company Cytogen regarding the setting of a record date for the purpose of closing the shareholder register for an upcoming Extraordinary General Meeting. It does not contain the full proxy materials or the meeting presentation itself, but rather serves as a formal regulatory notification of a corporate action. Given it does not fit into specific categories like dividend announcements or share buybacks, it falls under the general regulatory filing category.
2024-01-02 Korean
[기재정정]기타시장안내(최대주주의의무보유관련)(최대주주의 의무보유 대상 확인 관련)
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding 'Other Market Guidance' (기타시장안내) concerning the mandatory holding period of shares and convertible bonds by the company's largest shareholder. It details a correction to a previous filing and explains regulatory compliance requirements under KOSDAQ listing rules. Since it is a specific regulatory announcement regarding market compliance and shareholding status that does not fit into categories like M&A, dividends, or financial reports, it is classified as a Regulatory Filing (RNS).
2024-01-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, including acquisitions of convertible bonds and new shares, and lists the reporting entity (CanDx Holdings) and its special relations. This falls under the category of Major Shareholding Notification.
2023-12-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.